RxDoctor Payments Data

Robert Josephberg, MD

Retina Specialist · Hawthorne, NYNPI 1588601793

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.9% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations.

$7,209in general payments, 2019–2025

Across 122 payments — averaging $59.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$2K
  • AbbVie$1K
  • Astellas Pharma US Inc$600
  • Genentech USA, Inc.$593
  • Amgen$508
  • BD$414
  • plus $2K from 18 others

What the payments were for

  • Consulting fees$4146%
  • Food & beverage$6,76794%
  • Education$80%
  • Gifts$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,209 in reported general payments places this provider in the 70th percentile of 99 retina specialist providers in New York.

See all retina specialist providers in New York

Medicare billing

Part B allowed, 2024
$315,861
Medicare patients
268
Services billed
3,381

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Travoprost11$2,762
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat127$2,513
Latanoprost192$1,955
Ketorolac Tromethamine92$1,359
Brimonidine Tartrate71$1,112
Timolol Maleate81$666
Prednisolone Acetate13$624
Dorzolamide Hcl13$476
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha12$126

Paid to pharmacies, not to this prescriber.

Other retina specialist in Hawthorne

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →